Results
1 -
10 of
54
(Click
here to explore results)
Natural Product Chemistry for Drug Discovery, Chapter 12 From Natural Product to Clinical Trials: NPI-0052 (Salinosporamide A), a Marine Actinomycete-Derived Anticancer Agent . Kin S. Lam, G. Kenneth Lloyd, Saskia T. C. Neuteboom, Michael A. Palladino, Kobi M. Sethna, Matthew A. Spear, Barbara C. Potts
, 2009
, Pages 355-373
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 9 Pharmacokinetics and Metabolism of Compounds that Mimic Enzyme Transition States . Iain Gardner, Chris Barber, Martin Howard, Aarti Sawant, Kenny Watson
, 2010
, Pages 390-459
Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 13 Hsp90 Inhibitors in Clinic . Emin Avsar
, 2014
, Pages 336-378
Organic Chemistry of Drug Degradation, CHAPTER 3 Oxidative Degradation
, 2012
, Pages 48-109
Nutraceuticals and Human Health: The Food-to-supplement Paradigm, Chapter 8 Nutraceuticals in Hematological Malignancies . Matthew Tcheng, Alessia Roma, Paul A. Spagnuolo
, 2020
, Pages 122-139
Anti-fibrotic Drug Discovery, CHAPTER 6 Targeting the Ubiquitin Proteasome System in Pulmonary Fibrosis . Andrew J. Thorley, Simon Krautwald, David J. Rowlands
, 2020
, Pages 165-184
Nanomedicines: Design, Delivery and Detection, Chapter 13 Doxil® – the First FDA-approved Nano-drug: from Basics via CMC, Cell Culture and Animal Studies to Clinical Use . Yechezkel (Chezy) Barenholz
, 2016
, Pages 315-345
Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 12 The Cancer Super-chaperone Hsp90: Drug Targeting and Post-translational Regulation . Annerleim Walton-Diaz, Sahar Khan, Jane B. Trepel, Mehdi Mollapour, Len Neckers
, 2014
, Pages 318-335
Protein–Protein Interaction Regulators, CHAPTER 12 Small-molecule Inhibitors of Myc–Max Interaction and DNA Binding . Steven Fletcher, Edward V. Prochownik
, 2021
, Pages 302-338
Sustainable Synthesis of Pharmaceuticals: Using Transition Metal Complexes as Catalysts, Chapter 10 Tetravalent Boron-based Therapeutics . Q. Meng, M. Wang, M. G. H. Vicente
, 2018
, Pages 253-281